Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT5 | Q9NXA8 | 2/20 | 0.48 |
| ▸ | IL23R | Q5VWK5 | 3/20 | 0.42 |
| ▸ | NPY4R | P50391 | 9/20 | 0.42 |
| ▸ | NPY5R | Q15761 | 6/20 | 0.42 |
| ▸ | NPY1R | P25929 | 6/20 | 0.42 |
| ▸ | NPY2R | P49146 | 3/20 | 0.42 |
| ▸ | ALB | P02768 | 1/20 | 0.38 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30051657 | 0.96 | SIRT5 (0.53) | SIRT5IL23RNPY4RNPY5RNPY1R | |
| SCHEMBL30463260 | 0.96 | SIRT5 (0.53) | SIRT5IL23RNPY4RNPY5RNPY1R | |
| SCHEMBL30463279 | 0.96 | SIRT5 (0.53) | SIRT5IL23RNPY4RNPY5RNPY1R | |
| SCHEMBL31157647 | 0.96 | SIRT5 (0.53) | SIRT5IL23RNPY4RNPY5RNPY1R | |
| SCHEMBL31157760 | 0.96 | SIRT5 (0.53) | SIRT5IL23RNPY4RNPY5RNPY1R | |
| SCHEMBL30463278 | 0.96 | SIRT5 (0.53) | SIRT5IL23RNPY4RNPY5RNPY1R | |
| SCHEMBL12066140 | 0.96 | SIRT5 (0.53) | SIRT5IL23RNPY4RNPY5RNPY1R | |
| SCHEMBL30998021 | 0.96 | SIRT5 (0.53) | SIRT5IL23RNPY4RNPY5RNPY1R | |
| SCHEMBL30173882 | 0.96 | SIRT5 (0.53) | SIRT5IL23RNPY4RNPY5RNPY1R | |
| SCHEMBL30173825 | 0.96 | SIRT5 (0.53) | SIRT5IL23RNPY4RNPY5RNPY1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4144337-A1 | VITIS VINIFERA COSMETIC COMPOSITION | Guangzhou Jiyan Cosmetics Technology Co. Ltd. (CN) | 2023-03-08 | — | — | EP | disclosed |